Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.05B |
| 2 |
Texas Instruments
TXN
|
+$1.69B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Starbucks
SBUX
|
+$1.2B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$949M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.77B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.22B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.11B |
| 5 |
Procter & Gamble
PG
|
+$915M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Consumer Discretionary | 7.25% |
| 3 | Financials | 7.18% |
| 4 | Communication Services | 6.16% |
| 5 | Healthcare | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Sociedad Química y Minera de Chile
SQM
$19.1B
| $8.67M | ﹤0.01% |
212,701
+20,629
| +11% | +$953K |
|
|
WBA
1252
CALL
DELISTED
Walgreens Boots Alliance
WBA
| $8.65M | ﹤0.01% |
715,000
+652,500
| +1,044% | +$11.1M |
|
1253
FTAI Aviation
FTAI
$23B
| $8.64M | ﹤0.01% |
83,705
-81,564
| -49% | -$6.48M |
|
1254
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.4B
| $8.64M | ﹤0.01% |
140,127
+8,510
| +6% | +$534K |
|
1255
EXL Service
EXLS
$5.23B
| $8.61M | ﹤0.01% |
274,693
-120,216
| -30% | -$3.61M |
|
1256
Corcept Therapeutics
CORT
$12.3B
| $8.59M | ﹤0.01% |
264,443
-10,801
| -4% | -$296K |
|
1257
Oshkosh
OSK
$9.03B
| $8.58M | ﹤0.01% |
79,275
-52,963
| -40% | -$6.13M |
|
1258
United Parks & Resorts
PRKS
$2.14B
| $8.55M | ﹤0.01% |
157,429
+54,869
| +53% | +$2.87M |
|
1259
CALL
Novartis
NVS
$292B
| $8.48M | ﹤0.01% |
+79,700
| New | +$8M |
|
1260
STAG Industrial
STAG
$7.34B
| $8.48M | ﹤0.01% |
235,158
-27,845
| -11% | -$991K |
|
1261
Starwood Property Trust
STWD
$5.86B
| $8.47M | ﹤0.01% |
447,289
-1,250
| -0.3% | -$24.4K |
|
1262
CALL
Cogent Communications
CCOI
$686M
| $8.47M | ﹤0.01% |
+150,000
| New | +$8.95M |
|
1263
Murphy Oil
MUR
$5.66B
| $8.37M | ﹤0.01% |
202,840
-82,704
| -29% | -$3.6M |
|
1264
Sabesp
SBS
$18.9B
| $8.36M | ﹤0.01% |
3,206,816
| – | – |
|
1265
Diebold Nixdorf
DBD
$2.61B
| $8.34M | ﹤0.01% |
216,684
+136,437
| +170% | +$5.2M |
|
1266
RXO
RXO
$3.37B
| $8.32M | ﹤0.01% |
318,343
+26,093
| +9% | +$543K |
|
|
APLS
1267
DELISTED
Apellis Pharmaceuticals
APLS
| $8.32M | ﹤0.01% |
216,878
+191,086
| +741% | +$8.65M |
|
1268
Nu Holdings
NU
$69.3B
| $8.32M | ﹤0.01% |
645,289
+544,328
| +539% | +$6.34M |
|
1269
ProShares S&P 500 ex-Financials ETF
SPXN
$76.7M
| $8.31M | ﹤0.01% |
140,000
| – | – |
|
1270
Macerich
MAC
$7.34B
| $8.28M | ﹤0.01% |
536,101
+319,852
| +148% | +$4.89M |
|
1271
CALL
Neurocrine Biosciences
NBIX
$17B
| $8.26M | ﹤0.01% |
+60,000
| New | +$8.23M |
|
1272
Griffon
GFF
$4.02B
| $8.24M | ﹤0.01% |
129,011
+78,158
| +154% | +$5.29M |
|
1273
Performance Food Group
PFGC
$17.8B
| $8.23M | ﹤0.01% |
124,440
-80,159
| -39% | -$5.59M |
|
1274
Unity
U
$14.5B
| $8.21M | ﹤0.01% |
504,643
+170,724
| +51% | +$3.65M |
|
1275
BP
BP
$114B
| $8.18M | ﹤0.01% |
226,487
+41,704
| +23% | +$1.56M |
|
Similar funds
Barclays's Q2 2024 Portfolio in Review
As of Q2 2024, Barclays held 5,455 positions worth $327B, up 14% from $288B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Barclays deployed $29.4B of net new capital in Q2 2024, opening 406 new positions and adding to 1,053 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Apple, an estimated $2.77B trimmed.
- Barclays's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
- Barclays added most to CRH in Q2 2024, an estimated $2.05B increase.
- Barclays's biggest Q2 2024 reduction was Apple, cutting an estimated $2.77B.
- Barclays fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $212M.
- Barclays's ten largest holdings make up 42% of its $327B portfolio in Q2 2024.
- Barclays opened 406 new positions and closed 646 in Q2 2024.
- Barclays's portfolio value rose 14% quarter-over-quarter to $327B.
Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.